S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Baker Bros Advisors/Q1 2023

Baker Bros Advisors

Periodo: Q1 2023 Β· Depositato: 2023-05-15
Vedi su SEC EDGAR β†—
AUM
$18.38B
Valore totale del portafoglio
Posizioni
105
Titoli dichiarati
Prima Posizione
SGEN
51.7% $9.50B
Var. Trimestrali
+7 / -8
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2023-05-15) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
SGENSeagen Inc.$9.50B51.68%β€”β€”
51.7%
INCYIncyte Corporation$2.61B14.22%$72.27$116.86+61.7%
14.2%
ONCBeiGene, Ltd.$2.52B13.68%$215.53$297.65+38.1%
13.7%
ACADACADIA Pharmaceuticals Inc.$789.3M4.29%$18.82$25.97+38.0%
4.3%
MDGLMadrigal Pharmaceuticals, Inc.$374.3M2.04%$242.26$528.10+118.0%
2.0%
BMRNBioMarin Pharmaceutical Inc.$370.5M2.02%$97.24$58.99-39.3%
2.0%
IMCRImmunocore Holdings plc$124.6M0.68%$49.44$32.50-34.3%
0.7%
RYTMRhythm Pharmaceuticals, Inc.$115.9M0.63%$17.84$114.17+540.0%
0.6%
KODKodiak Sciences Inc.$107.3M0.58%$6.20$38.54+521.6%
0.6%
BCRXBioCryst Pharmaceuticals, Inc.$106.0M0.58%$8.34$9.84+18.0%
0.6%
ARGXargenx SE$104.4M0.57%$372.58$939.68+152.2%
0.6%
AKROAkero Therapeutics, Inc.$90.6M0.49%β€”β€”
0.5%
KYMRKymera Therapeutics, Inc.$85.3M0.46%$29.63$113.51+283.1%
0.5%
REPLReplimune Group, Inc.$80.8M0.44%$17.66$11.58-34.4%
0.4%
ABCLAbCellera Biologics Inc.$78.8M0.43%$7.54$8.11+7.6%
0.4%
SWTXSpringWorks Therapeutics, Inc.$70.9M0.39%β€”β€”
0.4%
TRDAEntrada Therapeutics, Inc.$70.5M0.38%$14.50$7.72-46.8%
0.4%
BMEABiomea Fusion, Inc.$65.4M0.36%$31.01$1.41-95.5%
0.4%
RVMDRevolution Medicines, Inc.$58.3M0.32%$21.66$189.24+773.7%
0.3%
PRLDPrelude Therapeutics Inc.$57.7M0.31%$5.70$4.91-13.9%
0.3%
MRTXMirati Therapeutics, Inc.$52.4M0.29%β€”β€”
0.3%
FGENFibroGen, Inc.$49.2M0.27%β€”β€”
0.3%
CERSCerus Corporation$47.7M0.26%$2.97$3.16+6.4%
0.3%
IGMSIGM Biosciences, Inc.$43.4M0.24%β€”β€”
0.2%
AVTEAerovate Therapeutics, Inc.$39.6M0.22%β€”β€”
0.2%
IMTXImmatics N.V.$35.8M0.19%$6.90$9.95+44.2%
0.2%
ROIVRoivant Sciences Ltd.$35.3M0.19%$7.38$35.13+376.0%
0.2%
NRIXNurix Therapeutics, Inc.$34.5M0.19%$8.88$23.97+169.9%
0.2%
KDNYChinook Therapeutics, Inc.$33.7M0.18%β€”β€”
0.2%
KNSAKiniksa Pharmaceuticals, Ltd.$30.1M0.16%$10.76$64.53+499.7%
0.2%

AttivitΓ  Trimestre su Trimestre

Q1 2023 vs. Q4 2022

Nuove Posizioni (7)

TickerEmittenteNozionale
BPMCBlueprint Medicines Corporation$15.0M
ALLOAllogene Therapeutics, Inc.$7.8M
MRSNMersana Therapeutics, Inc.$7.8M
GERNGeron Corporation$6.6M
SANASana Biotechnology, Inc.$6.5M
RLAYRelay Therapeutics, Inc.$4.7M
GLUEMonte Rosa Therapeutics, Inc.$2.9M

Posizioni Chiuse (8)

TickerEmittenteNozionale
ASNDAscendis Pharma A/S$605.1M
HZNPHorizon Therapeutics Public Ltd Co$110.3M
TVTXTravere Therapeutics, Inc.$25.8M
Insmed Incorporated$19.2M
CBAYCymaBay Therapeutics, Inc.$13.6M
ZYMEZymeworks Inc.$13.4M
ALTAltimmune, Inc.$10.8M
CINCCinCor Pharma, Inc.$9.9M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
INSMInsmed Incorporated$5.5M+1619.3%
LPTXLeap Therapeutics, Inc.$2.3M+1226.7%
RVMDRevolution Medicines, Inc.$53.0M+1111.2%+773.7%
SERASera Prognostics, Inc.$6.6M+787.6%
FATEFate Therapeutics, Inc.$7.3M+675.0%
ROIVRoivant Sciences Ltd.$29.5M+566.6%+376.0%
SMMTSummit Therapeutics Inc.$2.5M+215.2%
RNAMAvidity Biosciences, Inc.$5.8M+130.9%

Ridotte (7)

TickerEmittenteNozionaleVar. AzioniDal Deposito
VORXXXXVor Biopharma Inc.$-6.3M-56.8%
IDYAIDEAYA Biosciences, Inc.$-18.9M-50.1%
BMRNBioMarin Pharmaceutical Inc.$-418.1M-50.0%-39.3%
KDNYChinook Therapeutics, Inc.$-32.7M-42.6%
DSGNDesign Therapeutics, Inc.$-3.5M-9.4%
VSTMXXXXVerastem, Inc.$-0.3M-5.4%
AVTEAerovate Therapeutics, Inc.$-18.3M-0.7%
← Torna agli Hedge Fund